久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

韓國LG生命科學(xué) LG Life Sciences Ltd
LG集團所屬的LG生命科學(xué)株式會社是韓國大型綜合性制藥公司，公司將新藥研發(fā)作為公司發(fā)展的關(guān)鍵戰(zhàn)略，并已經(jīng)成功研發(fā)出世界水平的幾種新藥。LG生命科學(xué)秉承LG集團的經(jīng)營理念，“為顧客創(chuàng)造價值”和“尊重人格的經(jīng)營”。
北京樂金科技有限公司是LG集團旗下LG生命科學(xué)在中國的全資子公司。其前身是LG生命科學(xué)于2004年在北京設(shè)立的代表處。經(jīng)過幾年的探索和發(fā)展，根據(jù)總部的發(fā)展戰(zhàn)略部署，2011年1月1日北京代表處成立了法人公司，進行醫(yī)藥產(chǎn)品的引進和市場拓展等業(yè)務(wù)。產(chǎn)品涵蓋藥品、醫(yī)療器械、醫(yī)學(xué)美容、疫苗、診斷試劑和保健六大類。目前已在中國上市的產(chǎn)品有基因工程產(chǎn)品尤得盼?（Eutropin?，重組人生長激素）、阿司伯根?（重組人促紅細(xì)胞生成素）、吉速星?（Factive?，吉米沙星原料藥和片劑）、眼科手術(shù)耗材Hyal2000?（醫(yī)用透明質(zhì)酸鈉凝膠）、純天然護膚品安特柔系列（ATOverol?）和HCA&CLA抗衰老系列產(chǎn)品。正在注冊中的有長效生長激素、注射美容類玻尿酸系列產(chǎn)品。

LG生命科學(xué)將繼續(xù)致力于把世界一流的醫(yī)藥產(chǎn)品和技術(shù)引進到中國，服務(wù)于中國人民的健康。

        
 In the process, corporate value is being raised as we strive to attain our goal of being a top-tier pharmaceutical maker in the global market.

Our involvement in pharmaceuticals dates back to 1981, when we
began genetic engineering research as a division of LG Chemical. Since
then, we have focused on the development of synthetic and bioengineered drugs, and we have enjoyed noteworthy success. For example, our quinolone antibiotic FACTIVE? became the first-ever new drug developed in Korea to receive FDA approval in 2003. It is now available in the US market and sales are growing steadily.

The life sciences industry is committed to promoting human health and longevity. This business also
represents unlimited possibilities and potential for growth.

LG Life Sciences is contributing to the improvement of people health and life quality and is firmly
established as the Korean leader of this strategically important industry. In the future, all LG Life
Sciences employees will continue to strive for global prominence while operating as a highly ethical
corporation that has the public trust.